Acute Porphyria Drug Database

J07AP01 - Typhoid, Oral, Live Attenuated
Propably not porphyrinogenic
PNP

Side effects
Common adverse reactions of the oral typhoid vaccine that can be confused with an acute porphyric attack are abdominal pain, nausea, diarrhoea, vomiting. These side effects may potentially be porphyrinogenic if leading to a decrease in carbohydrate intake. Also fever and influenza-like illness are common side effects of the vaccine and it is possible that this can trigger an acute porphyric attack in the same way as infections are known to.
Rationale
Based on the pharmacokinetics of the typhoid, oral, live attenuated vaccine, there are no conceivable porphyrinogenic effects.
Chemical description
Live attenuated salmonella enterica serovar Typhi.
Therapeutic characteristics
For active immunization against typhoid fever in children aged 6 years and over, adults and elderly. The vaccine is administered orally, in form of three capsules taken over five days.

References

  1. Government bodies
  2. Norwegian Institute of Public Health. Vaksinasjonsveilederen. www.fhi.no (updated 13.10.2015). #1857
  3. Summary of Product Characteristics
  4. The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). Vivotif. (Last edition: 31.03 2015). #1870

Similar drugs
Explore alternative drugs in similar therapeutic classes J07A / J07AP or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙